Irish medical device maker Coviden has revealed that it has received the CE Mark of Approval to market its Nellcor Respiration Rate System that can be used in keeping track of the patient's respiration rate continuously through one finger sensor.
The device is a combination of Coviden's Adult Respiratory Sensor, Nellcor Respiration Rate Version 2.0 software and Nellcor Bedside Respiratory Patient Monitoring System, both of which have also received the CE Mark of approval.
The company revealed that the device will provide accurate data with regards to the respiration rate of a patient through a continuous, non-invasive patient monitoring platform.
The Respiration Rate System has been backed by a number of doctors, including Dr Graham Douglas, Respiratory Unit, Aberdeen Royal Infirmary, who said, "The methods we currently have available to monitor respiration rate are not always accurate, despite the fact that it is a critical vital sign. The Respiration Rate system from Covidien gives us a better picture of a patient's overall respiratory status, does not change the workflow of our clinical staff and allows us to better provide effective treatment through a finger sensor that is familiar to clinicians and comfortable for patients."